Based on the analysis of BCAT1 immunostaining (Fig. 3A), we subdivided 72 lung primary adenocarcinoma samples into a high BCAT1 expression group (including 38 cases) and a low expression group (including 34 cases). The gene discussed is BCAT1; the disease is adenocarcinoma.